PLASMA PROTEIN THERAPEUTICS ASSOCIATION for PLASMA PROTEIN THERAPEUTICS ASSOCIATION
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Education visits to House and Senate offices relating to plasma protein therapies and the rare disease patients that use them and the economic value as well as the need for continued Source plasma donations. The Affordable Care Act, provisions relating to essential health benefits and patient protections. Medicare Part B provisions relating to home infusion of IVIG, particularly in CIPD. CMS programs relating to proposed rules, including most favored nation and international pricing index and use of foreign reference pricing. HCR that moves U.S. towards single decisionmakers and government negotiations. HR 3 Lowering Drug Costs Now Act provisions relating to drug reimbursement in Medicare. Issues relating to COVID and plasma protein products and 116th Congress "Plasma Donation Awareness Act" and reintroduction in 117th Congress. Activity related to cross border donation of plasma and impact on patients.
Foreign entity interest: GRIFOLS S.A.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIE BIRKOFER | — |
| AMY CHEVALIER EFANTIS | Legislative Director, Rep. Artur Davis; Legislative Assistant, Rep. Tom Barrett |
| THOMAS B LILBURN | — |
| BRENNA RAINES | — |
| TIMOTHY A. SWOPE | — |
Taxation/Internal Revenue Code TAX
The reduction and stabilization of the tax credit for the Orphan Drug Act and how it affects plasma protein therapies and their innovation.
Foreign entity interest: Grifols S.A.
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS B LILBURN | — |
Medicare/Medicaid MMM
The Affordable Care Act, provisions relating to essential health benefits and patient protections. Medicare Part B provisions relating to home infusion of IVIG, particularly in CIPD. CMS programs relating to proposed rules, including most favored nation and international pricing index. HR 3 Lowering Drug Costs Now Act provisions relating to drug reimbursement in Medicare. Issues relating to COVID and plasma protein products and 116th Congress "Plasma Donation Awareness Act" and reintroduction in 117th Congress. Activity relating to cross border donation of plasma.
Foreign entity interest: GRIFOLS S.A.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIE BIRKOFER | — |
| AMY CHEVALIER EFANTIS | Legislative Director, Rep. Artur Davis; Legislative Assistant, Rep. Tom Barrett |
| THOMAS B LILBURN | — |
| BRENNA RAINES | — |
| TIMOTHY A. SWOPE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.